Last updated November 2, 2026 · Published by myLabCompliance, one of the products discussed

LIS vs LIMS for Quality Control: Clinical vs Manufacturing Labs

What it is: LIS vs LIMS quality control refers to the two different ways laboratory software handles quality control. A LIMS (laboratory information management system) is built around samples, batches and lots in manufacturing, research and testing labs, and its QC checks whether a product or sample meets a specification. A LIS (laboratory information system) is built around patients, orders and results in clinical labs, and its QC checks whether a test system is in control before patient results are released under CLIA.

Short answer: QC in a LIMS asks "does this batch meet its specification, and was the instrument calibrated?" QC in a LIS asks "did today's control runs pass, so patient results can be reported?" The first is driven by GMP rules such as FDA 21 CFR Part 211 and by ISO/IEC 17025. The second is driven by CLIA, mainly 42 CFR 493.1256. This page compares the two and explains where a dedicated QC and compliance system fits next to either one.

Definitions: LIS, LIMS and laboratory QC

LIMS (laboratory information management system). Software that tracks samples, batches, lots, tests, specifications, instruments and reagents. It is common in pharmaceutical, biotech, food, environmental, chemical and research labs. The record is centered on the sample or lot.
LIS (laboratory information system). Software that manages patient test orders, specimens, results and reports in clinical labs, usually interfaced to analyzers and an electronic health record. The record is centered on the patient and the order.
Quality control (QC). The checks a lab runs to show its results can be trusted. In manufacturing, QC often means the QC laboratory function that tests and releases materials and products. In clinical labs, QC usually means running control materials with known values alongside patient samples.
Quality assurance and compliance. The wider program around QC: procedures, training and competency, equipment records, proficiency testing, audits and corrective action.

The two terms overlap. Some vendors sell one platform with clinical and non-clinical editions, and some clinical labs (for example toxicology or molecular labs) use a LIMS. What matters for QC is which rules your lab works under, not the product label.

QC in a LIMS: manufacturing, testing and research labs

In a LIMS, QC is tied to a sample, batch or lot and to a specification. Typical QC functions are:

Batch and lot tracking. Each raw material, intermediate and finished product lot gets a record with its samples, tests, results and status (for example quarantined, released or rejected). Reagents, standards and reference materials are tracked by lot and expiry as well.
Specification enforcement. Each product has limits for each test. The LIMS compares results with the specification, flags out-of-specification (OOS) results and can block release until the result is investigated and reviewed.
Instrument calibration and maintenance. Instruments carry calibration schedules and status, so an instrument that is overdue can be blocked from use and results can be traced to a calibrated instrument.
Stability and environmental monitoring. Many LIMS products schedule stability pulls and environmental samples, although this varies by product.
Review, approval and audit trail. Results are reviewed and approved by a second person, with electronic records and signatures that labs subject to FDA rules manage under 21 CFR Part 11.

GMP drivers. For U.S. drug manufacturers, 21 CFR 211.160 requires scientifically sound specifications, standards, sampling plans and test procedures, and calibration of instruments at suitable intervals under a written program. 21 CFR 211.165 covers testing and release of each batch, 21 CFR 211.192 requires review of records and investigation of unexplained discrepancies, and 21 CFR 211.194 sets out what laboratory records must contain.

ISO/IEC 17025 drivers. Testing and calibration labs accredited to ISO/IEC 17025:2017 must manage equipment (clause 6.4), establish metrological traceability (6.5), keep technical records (7.5), monitor the validity of results (7.7, which includes using reference materials, QC charts, replicate testing and interlaboratory comparisons) and control nonconforming work (7.10). A LIMS is a common way to hold this evidence, but the standard does not require one.

QC in a LIS: clinical labs under CLIA

In a LIS, QC is tied to a test system and a run. The question is whether control results are acceptable before patient results go out. Typical QC functions are:

Control runs. Control materials at two or more levels are run on each analyzer, and the LIS or middleware stores each result with its level, lot, test, instrument and time.
Levey-Jennings charts. Control results are plotted against the lab's mean and standard deviation (SD) for each level so shifts and trends are visible.
Westgard multirules. Rules such as 1_3s, 2_2s, R_4s, 4_1s and 10_x flag runs that should be rejected, with 1_2s often used only as a warning.
Autoverification. Many LIS and middleware products can release patient results automatically when they pass rules the lab defines, such as QC status, delta checks, critical values and instrument flags. Results that fail a rule are held for a technologist. Autoverification rules are written and validated by the lab; CLIA does not prescribe them.
Holds and release. When QC fails, the system can hold patient results for that test and instrument until the problem is fixed and controls pass.

CLIA drivers. Levey-Jennings charts and Westgard rules are common tools, not regulatory terms. The rules themselves are in 42 CFR Part 493:

42 CFR 493.1256 Control procedures. For each quantitative procedure, at least two control materials of different concentrations at least once each day patient specimens are assayed, unless an alternative such as an IQCP applies; acceptability criteria for each control lot; acceptable QC before patient results are reported; and documentation of all control activity.
42 CFR 493.1281 Comparison of test results. When a lab performs the same test using different methodologies or instruments, or at multiple testing sites, it must have a system that twice a year evaluates and defines the relationship between results.
42 CFR 493.1282 Corrective actions, including review of patient results back to the last acceptable control run.
42 CFR 493.1255 Calibration and calibration verification, the clinical counterpart to LIMS calibration schedules.
42 CFR 493.1105 Record retention: QC and analytic system records kept for at least two years.

Side-by-side: QC in a LIMS vs QC in a LIS

Aspect	LIMS (manufacturing, testing, research)	LIS (CLIA clinical lab)
Record centered on	Sample, batch or lot	Patient, order and test system run
Main QC question	Does the material meet its specification?	Are controls acceptable so patient results can be reported?
Typical QC tools	Specifications, OOS flags, lot status, stability, control charts for some methods	Control levels, Levey-Jennings charts, Westgard rules, autoverification
Failure handling	OOS investigation and batch disposition	Run rejection, corrective action, patient look-back
Calibration	Written calibration program and instrument status	Calibration and calibration verification per test system
Comparing methods or sites	Method transfer and interlaboratory comparison	Comparison of test results twice a year (493.1281)
Main rules	21 CFR 211, 21 CFR Part 11, ISO/IEC 17025	42 CFR 493 (CLIA), accreditor checklists, state rules
Typical gap	Training, documents and equipment may live in separate quality systems	Corrective action, competency, procedures and PT often live outside the LIS

Neither column is better. Each reflects the rules the lab must meet. A clinical lab that adopts a LIMS still has to meet CLIA, and a manufacturing lab that uses clinical-style control charts still has to meet GMP or ISO/IEC 17025.

What a LIS QC module usually leaves out

A LIS is very good at moving results and holding them when QC fails. Surveyors, though, ask about more than the flag. In a CLIA survey, questions often follow the QC record outward:

Who reviewed the QC, and when? Is the review documented at the bench and by a supervisor or director?
What was done after a rule failed? Is there a root cause, a fix and a patient look-back under 493.1282?
How were acceptability criteria set for a new control lot?
Is the twice-yearly comparison under 493.1281 done and signed for every test run on more than one instrument?
Was the person who ran and accepted QC competent on that test system?
Does the written procedure match the rules actually configured?

Much of that evidence sits in comment fields, spreadsheets or paper binders. That is the gap a dedicated QC and compliance system is designed to close. Our comparison of a LIMS QC module vs. a dedicated QC and compliance system goes deeper.

Where a dedicated QC and compliance system fits

myLabCompliance is CLIA compliance management software for clinical labs. It is not a LIS or a LIMS, and it is not designed for GMP batch release. It sits next to the LIS and holds the QC and compliance records a CLIA lab is surveyed on. Its QC software page lists:

QC scheduling by instrument and test, with group and instrument QC profiles.
Package insert records with QC levels, target means, high and low limits, units, lot numbers and expiration details, plus control lot management.
Levey-Jennings charts with multiple levels, date range and level selection, CSV export and PDF-oriented reports.
Westgard rule violation detection.
QC failure fields for status, retry sessions, attempt sequence, level-specific corrective action, root cause and resolution notes.
IQCP workflows.

Around QC, the platform holds personnel files and competency assessments, document control with versions and e-signatures, equipment maintenance and calibration, proficiency testing, method validation (linearity, precision, accuracy, AMR) and audit trails.

Its public pages do not describe autoverification, patient result release or a LIS interface, so the LIS stays the system that holds and releases patient results. Labs that want a broader view can read about standalone QC management software for clinical labs and our lab quality control software guide.

How to choose for your lab

Manufacturing, pharma or ISO/IEC 17025 testing lab: look at a LIMS with specification, lot and calibration management, and confirm Part 11 controls if FDA rules apply. A CLIA tool is not the right fit.
Hospital or reference clinical lab with an interfaced LIS: keep run-level QC flags and holds in the LIS or middleware, and decide where QC review, corrective action, 493.1281 comparisons and competency records will live.
Physician office or clinic lab with mostly manual or waived tests: the LIS QC module may be thin or absent, so a dedicated QC and compliance system can hold QC logs, charts and failure records.
Clinical lab using a LIMS: check that the LIMS can meet every element of 493.1256, including two levels per day for quantitative tests and documented acceptability criteria per lot.

See how myLabCompliance holds QC scheduling, Levey-Jennings review, Westgard flags and QC failure records next to competency, documents and equipment for a CLIA lab.

Book a myLabCompliance demo

FAQs

What is the difference between QC in a LIS and QC in a LIMS?

QC in a LIMS checks whether samples, batches or lots meet a specification and whether instruments are calibrated, under rules such as 21 CFR 211 or ISO/IEC 17025. QC in a LIS checks whether control runs are acceptable before patient results are reported, under CLIA rules in 42 CFR 493.1256.

Does CLIA require Levey-Jennings charts or Westgard rules?

No. 42 CFR 493.1256 requires control procedures, acceptability criteria, acceptable QC before reporting and documentation. Levey-Jennings charts and Westgard rules are common ways to meet those requirements, not named requirements.

What does 42 CFR 493.1281 require?

If a lab performs the same test with different methods or instruments, or at more than one site, it must have a system that twice a year evaluates and defines the relationship between the results.

Is autoverification required under CLIA?

No. Autoverification is an optional LIS or middleware function. If a lab uses it, the lab defines and validates the rules, including how QC status affects release.

Which regulations drive QC in a LIMS?

For U.S. drug manufacturing, FDA 21 CFR Part 211 (for example 211.160, 211.165, 211.192 and 211.194) and 21 CFR Part 11 for electronic records. For accredited testing and calibration labs, ISO/IEC 17025:2017, including clause 7.7 on ensuring the validity of results.

Can a clinical lab use a LIMS instead of a LIS?

Yes, some do. The software label does not change the rules: the lab still has to meet 42 CFR Part 493.

Is myLabCompliance a LIS or LIMS?

No. It is CLIA compliance management software with a QC module that covers QC scheduling, control lots, Levey-Jennings charts, Westgard rule violation detection, QC failure records and IQCP workflows, alongside personnel, documents, equipment, PT and validation.

Sources

Related myLabCompliance pages

Product names mentioned in our related pages belong to their owners. myLabCompliance is independent software and is not affiliated with any LIS or LIMS vendor. Regulations are linked to eCFR, CMS and ISO; confirm current text before relying on it. This page is educational and is not legal or regulatory advice.